By the way, I am a PhD student at the Centre for Biomedical Ethics under the Yong Loo Lin School of Medicine, which is commissioned to be in charge of the validation of the idea in Singapore. I am not sure what I, or even our centre can do (personally, I didn’t know this was happening until I saw this post). But if anyone can think of anything I should do, let me know. (if you think there might be infohazard, feel free to PM or email me)
Clarification: They commissioned the YLL School of Medicine, particularly the Life Science Institute, to validate the idea of using CL1 to build datacentres. Of course they won’t commission a centre for bioethics to do that.
Do you know if the Centre for Biomedical Ethics was consulted? It would also be very interesting to know how the university and IRB approval worked here. Not just the initial validation, but whether these approvals were granted with the knowledge that this would transition from a research prototype to commercial deployment at scale. Any of these answers would be very good to know (feel free to DM me if you want). In general you seemed uniquely positioned here, really glad you read the post!
Excuse me for posting this two times:
By the way, I am a PhD student at the Centre for Biomedical Ethics under the Yong Loo Lin School of Medicine, which is commissioned to be in charge of the validation of the idea in Singapore. I am not sure what I, or even our centre can do (personally, I didn’t know this was happening until I saw this post). But if anyone can think of anything I should do, let me know. (if you think there might be infohazard, feel free to PM or email me)
Clarification: They commissioned the YLL School of Medicine, particularly the Life Science Institute, to validate the idea of using CL1 to build datacentres. Of course they won’t commission a centre for bioethics to do that.
Do you know if the Centre for Biomedical Ethics was consulted? It would also be very interesting to know how the university and IRB approval worked here. Not just the initial validation, but whether these approvals were granted with the knowledge that this would transition from a research prototype to commercial deployment at scale. Any of these answers would be very good to know (feel free to DM me if you want). In general you seemed uniquely positioned here, really glad you read the post!
I am trying to ask. I will PM you when I get an answer.
I will try to investigate too.
Please feel free to email me to keep in touch. Or add me on linkedin.